Open AccessLong-Term Efficacy and Safety of Zonisamide Monotherapy in Epilepsy Patients
Author(s) -
Sung-Pa Park,
SunYoung Kim,
YangHa Hwang,
HoWon Lee,
Chung-Kyu Suh,
Soonhak Kwon
Publication year - 2007
Publication title -
journal of clinical neurology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.208
H-Index - 45
eISSN - 2005-5013
pISSN - 1738-6586
DOI - 10.3988/jcn.2007.3.4.175
Subject(s) - zonisamide , epilepsy , adverse effect , medicine , partial seizures , weight loss , pediatrics , anticonvulsant , anesthesia , psychiatry , topiramate , obesity
Zonisamide (ZNS) is a useful antiepileptic drug with a broad therapeutic spectrum. However, there is limited information on the long-term use of ZNS as a monotherapy. This study investigated the long-term effects of ZNS as a monotherapy for the treatment of epilepsy.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom